{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,27]],"date-time":"2025-12-27T10:03:52Z","timestamp":1766829832643,"version":"3.44.0"},"reference-count":44,"publisher":"Elsevier BV","issue":"10-11","license":[{"start":{"date-parts":[[2015,7,1]],"date-time":"2015-07-01T00:00:00Z","timestamp":1435708800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,7,1]],"date-time":"2015-07-01T00:00:00Z","timestamp":1435708800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"JSPS KAKENHI","award":["22249017","25253040"],"award-info":[{"award-number":["22249017","25253040"]}]},{"DOI":"10.13039\/501100008660","name":"Kurozumi Medical Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100008660","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Biochemistry"],"published-print":{"date-parts":[[2015,7]]},"DOI":"10.1016\/j.clinbiochem.2015.03.019","type":"journal-article","created":{"date-parts":[[2015,4,11]],"date-time":"2015-04-11T02:07:37Z","timestamp":1428718057000},"page":"690-697","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Possible involvement of sphingomyelin in the regulation of the plasma sphingosine 1-phosphate level in human subjects"],"prefix":"10.1016","volume":"48","author":[{"given":"Ryunosuke","family":"Ohkawa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Makoto","family":"Kurano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuko","family":"Mishima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takahiro","family":"Nojiri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasunori","family":"Tokuhara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatsuya","family":"Kishimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuhiro","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shigeo","family":"Okubo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shigemi","family":"Hosogaya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yukio","family":"Ozaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiromitsu","family":"Yokota","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koji","family":"Igarashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hitoshi","family":"Ikeda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Minoru","family":"Tozuka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yutaka","family":"Yatomi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinbiochem.2015.03.019_bb0005","doi-asserted-by":"crossref","first-page":"575","DOI":"10.2174\/138161206775474404","article-title":"Sphingosine 1-phosphate in vascular biology: possible therapeutic strategies to control vascular diseases","volume":"12","author":"Yatomi","year":"2006","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.clinbiochem.2015.03.019_bb0010","first-page":"11","article-title":"Role of sphingosine 1-phosphate receptor type 1 in lymphocyte egress from secondary lymphoid tissues and thymus","volume":"3","author":"Chiba","year":"2006","journal-title":"Cell Mol Immunol"},{"key":"10.1016\/j.clinbiochem.2015.03.019_bb0015","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.jaci.2014.01.037","article-title":"Sphingosine-1-phosphate receptors control B-cell migration through signaling components associated with primary immunodeficiencies, chronic lymphocytic leukemia, and multiple sclerosis","volume":"134","author":"Sic","year":"2014","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.clinbiochem.2015.03.019_bb0020","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1194\/jlr.R046656","article-title":"Export of sphingosine-1-phosphate and cancer progression","volume":"55","author":"Takabe","year":"2014","journal-title":"J Lipid Res"},{"key":"10.1016\/j.clinbiochem.2015.03.019_bb0025","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1172\/JCI10905","article-title":"Edg-1, the G protein-coupled receptor for sphingosine-1-phosphate, is essential for vascular maturation","volume":"106","author":"Liu","year":"2000","journal-title":"J Clin Invest"},{"key":"10.1016\/j.clinbiochem.2015.03.019_bb0030","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1111\/jdi.12232","article-title":"Modulation of sphingosine-1-phosphate and apolipoprotein M levels in the plasma, liver and kidneys in streptozotocin-induced diabetic mice","volume":"5","author":"Nojiri","year":"2014","journal-title":"J Diabetes Investig"},{"key":"10.1016\/j.clinbiochem.2015.03.019_bb0035","first-page":"1217","article-title":"Induction of insulin secretion by apolipoprotein M, a carrier for sphingosine 1-phosphate","volume":"2014","author":"Kurano","year":"1841","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.clinbiochem.2015.03.019_bb0040","doi-asserted-by":"crossref","first-page":"e00172","DOI":"10.1002\/phy2.172","article-title":"Sphingosine-1-phosphate acts as a key molecule in the direct mediation of renal fibrosis","volume":"1","author":"Shiohira","year":"2013","journal-title":"Physiol Rep"},{"key":"10.1016\/j.clinbiochem.2015.03.019_bb0050","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1111\/j.1600-6143.2004.00476.x","article-title":"FTY720: sphingosine 1-phosphate receptor-1 in the control of lymphocyte egress and endothelial barrier function","volume":"4","author":"Brinkmann","year":"2004","journal-title":"Am J Transplant"},{"key":"10.1016\/j.clinbiochem.2015.03.019_bb0055","doi-asserted-by":"crossref","first-page":"161","DOI":"10.2174\/138161206775193109","article-title":"Lysophospholipid receptors as potential drug targets in tissue transplantation and autoimmune diseases","volume":"12","author":"Chun","year":"2006","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.clinbiochem.2015.03.019_bb0060","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/nrm1103","article-title":"Sphingosine-1-phosphate: an enigmatic signalling lipid","volume":"4","author":"Spiegel","year":"2003","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.clinbiochem.2015.03.019_bb0065","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/S1388-1981(02)00139-7","article-title":"Signaling of sphingosine-1-phosphate via the S1P\/EDG-family of G-protein-coupled receptors","volume":"1582","author":"Kluk","year":"2002","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.clinbiochem.2015.03.019_bb0070","first-page":"CR490","article-title":"Plasma sphingosine-1-phosphate concentration is reduced in patients with myocardial infarction","volume":"15","author":"Knapp","year":"2009","journal-title":"Med Sci Monit"},{"key":"10.1016\/j.clinbiochem.2015.03.019_bb0075","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1159\/000362993","article-title":"HDL-bound sphingosine 1-phosphate (S1P) predicts the severity of coronary artery atherosclerosis","volume":"34","author":"Sattler","year":"2014","journal-title":"Cell Physiol Biochem"},{"key":"10.1016\/j.clinbiochem.2015.03.019_bb0080","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/j.cca.2010.02.063","article-title":"Plasma concentration of bioactive lipid mediator sphingosine 1-phosphate is reduced in patients with chronic hepatitis C","volume":"411","author":"Ikeda","year":"2010","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.clinbiochem.2015.03.019_bb0085","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1097\/MCA.0000000000000033","article-title":"Increased plasma sphingosine-1-phosphate in obese individuals and its capacity to increase the expression of plasminogen activator inhibitor-1 in adipocytes","volume":"24","author":"Ito","year":"2013","journal-title":"Coron Artery Dis"},{"key":"10.1016\/j.clinbiochem.2015.03.019_bb0090","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1097\/MCA.0000000000000082","article-title":"TNF-alpha production in NKT cell hybridoma is regulated by sphingosine-1-phosphate: implications for inflammation in atherosclerosis","volume":"25","author":"Ito","year":"2014","journal-title":"Coron Artery Dis"},{"key":"10.1016\/j.clinbiochem.2015.03.019_bb0095","doi-asserted-by":"crossref","first-page":"5291","DOI":"10.1074\/jbc.272.8.5291","article-title":"Sphingosine 1-phosphate induces platelet activation through an extracellular action and shares a platelet surface receptor with lysophosphatidic acid","volume":"272","author":"Yatomi","year":"1997","journal-title":"J Biol Chem"},{"key":"10.1016\/j.clinbiochem.2015.03.019_bb0100","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/1476-511X-12-20","article-title":"Sphingosine 1-phosphate release from platelets during clot formation: close correlation between platelet count and serum sphingosine 1-phosphate concentration","volume":"12","author":"Ono","year":"2013","journal-title":"Lipids Health Dis"},{"key":"10.1016\/j.clinbiochem.2015.03.019_bb0105","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1126\/science.1139221","article-title":"Promotion of lymphocyte egress into blood and lymph by distinct sources of sphingosine-1-phosphate","volume":"316","author":"Pappu","year":"2007","journal-title":"Science"},{"key":"10.1016\/j.clinbiochem.2015.03.019_bb0110","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1258\/acb.2007.007189","article-title":"Plasma sphingosine-1-phosphate measurement in healthy subjects: close correlation with red blood cell parameters","volume":"45","author":"Ohkawa","year":"2008","journal-title":"Ann Clin Biochem"},{"key":"10.1016\/j.clinbiochem.2015.03.019_bb0120","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0090-6980(01)00103-4","article-title":"Sphingosine 1-phosphate: synthesis and release","volume":"64","author":"Yatomi","year":"2001","journal-title":"Prostaglandins Other Lipid Mediat"},{"key":"10.1016\/j.clinbiochem.2015.03.019_bb0125","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1161\/CIRCRESAHA.107.165845","article-title":"Vascular endothelium as a contributor of plasma sphingosine 1-phosphate","volume":"102","author":"Venkataraman","year":"2008","journal-title":"Circ Res"},{"key":"10.1016\/j.clinbiochem.2015.03.019_bb0130","doi-asserted-by":"crossref","first-page":"2614","DOI":"10.1161\/01.ATV.20.12.2614","article-title":"Plasma sphingomyelin level as a risk factor for coronary artery disease","volume":"20","author":"Jiang","year":"2000","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.clinbiochem.2015.03.019_bb0135","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1743-7075-3-5","article-title":"Further evaluation of plasma sphingomyelin levels as a risk factor for coronary artery disease","volume":"3","author":"Schlitt","year":"2006","journal-title":"Nutr Metab (Lond)"},{"key":"10.1016\/j.clinbiochem.2015.03.019_bb0140","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1093\/aje\/kwj140","article-title":"Plasma sphingomyelin and subclinical atherosclerosis: findings from the multi-ethnic study of atherosclerosis","volume":"163","author":"Nelson","year":"2006","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.clinbiochem.2015.03.019_bb0145","doi-asserted-by":"crossref","first-page":"39436","DOI":"10.1074\/jbc.M205623200","article-title":"Identification of human plasma lysophospholipase D, a lysophosphatidic acid-producing enzyme, as autotaxin, a multifunctional phosphodiesterase","volume":"277","author":"Tokumura","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1016\/j.clinbiochem.2015.03.019_bb0150","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1083\/jcb.200204026","article-title":"Autotaxin has lysophospholipase D activity leading to tumor cell growth and motility by lysophosphatidic acid production","volume":"158","author":"Umezu-Goto","year":"2002","journal-title":"J Cell Biol"},{"key":"10.1016\/j.clinbiochem.2015.03.019_bb0155","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1093\/clinchem\/48.6.891","article-title":"Evaluation of the anticoagulants EDTA and citrate, theophylline, adenosine, and dipyridamole (CTAD) for assessing platelet activation on the ADVIA 120 hematology system","volume":"48","author":"Macey","year":"2002","journal-title":"Clin Chem"},{"key":"10.1016\/j.clinbiochem.2015.03.019_bb0160","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1016\/j.clinbiochem.2012.07.093","article-title":"Development of an enzymatic assay for sphingomyelin with rapid and automatable performances: analysis in healthy subjects and coronary heart disease patients","volume":"45","author":"Ohkawa","year":"2012","journal-title":"Clin Biochem"},{"key":"10.1016\/j.clinbiochem.2015.03.019_bb0165","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/S0009-9120(02)00327-2","article-title":"An enzymatic assay for lysophosphatidylcholine concentration in human serum and plasma","volume":"35","author":"Kishimoto","year":"2002","journal-title":"Clin Biochem"},{"key":"10.1016\/j.clinbiochem.2015.03.019_bb0170","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1093\/jn\/116.1.50","article-title":"Choline, phosphatidylcholine and sphingomyelin in human and bovine milk and infant formulas","volume":"116","author":"Zeisel","year":"1986","journal-title":"J Nutr"},{"key":"10.1016\/j.clinbiochem.2015.03.019_bb0175","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/0009-8981(77)90465-X","article-title":"A new enzymatic method for determination of serum choline-containing phospholipids","volume":"79","author":"Takayama","year":"1977","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.clinbiochem.2015.03.019_bb0180","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.cca.2007.10.005","article-title":"Validation of an autotaxin enzyme immunoassay in human serum samples and its application to hypoalbuminemia differentiation","volume":"388","author":"Nakamura","year":"2008","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.clinbiochem.2015.03.019_bb0185","first-page":"5446","article-title":"Autotaxin hydrolyzes sphingosylphosphorylcholine to produce the regulator of migration, sphingosine-1-phosphate","volume":"63","author":"Clair","year":"2003","journal-title":"Cancer Res"},{"key":"10.1016\/j.clinbiochem.2015.03.019_bb0190","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1194\/jlr.D800028-JLR200","article-title":"Lipid profiling of FPLC-separated lipoprotein fractions by electrospray ionization tandem mass spectrometry","volume":"50","author":"Wiesner","year":"2009","journal-title":"J Lipid Res"},{"key":"10.1016\/j.clinbiochem.2015.03.019_bb0195","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1046\/j.1523-1747.2000.00072.x","article-title":"High-expression of sphingomyelin deacylase is an important determinant of ceramide deficiency leading to barrier disruption in atopic dermatitis","volume":"115","author":"Hara","year":"2000","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.clinbiochem.2015.03.019_bb0200","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1042\/bj3550189","article-title":"Sphingosylphosphocholine is a naturally occurring lipid mediator in blood plasma: a possible role in regulating cardiac function via sphingolipid receptors","volume":"355","author":"Liliom","year":"2001","journal-title":"Biochem J"},{"key":"10.1016\/j.clinbiochem.2015.03.019_bb0205","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1023\/A:1022501702403","article-title":"Sphingosylphosphorylcholine in Niemann\u2013Pick disease brain: accumulation in type A but not in type B","volume":"24","author":"Rodriguez-Lafrasse","year":"1999","journal-title":"Neurochem Res"},{"key":"10.1016\/j.clinbiochem.2015.03.019_bb0210","doi-asserted-by":"crossref","first-page":"25822","DOI":"10.1074\/jbc.M605142200","article-title":"Autotaxin stabilizes blood vessels and is required for embryonic vasculature by producing lysophosphatidic acid","volume":"281","author":"Tanaka","year":"2006","journal-title":"J Biol Chem"},{"key":"10.1016\/j.clinbiochem.2015.03.019_bb0215","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1016\/S0022-2275(20)30464-8","article-title":"Secretion of a lysophospholipase D activity by adipocytes: involvement in lysophosphatidic acid synthesis","volume":"43","author":"Gesta","year":"2002","journal-title":"J Lipid Res"},{"key":"10.1016\/j.clinbiochem.2015.03.019_bb0230","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1159\/000362992","article-title":"Sphingosine 1-phosphate in blood: function, metabolism, and fate","volume":"34","author":"Thuy","year":"2014","journal-title":"Cell Physiol Biochem"},{"key":"10.1016\/j.clinbiochem.2015.03.019_bb0235","doi-asserted-by":"crossref","first-page":"9613","DOI":"10.1073\/pnas.1103187108","article-title":"Endothelium-protective sphingosine-1-phosphate provided by HDL-associated apolipoprotein M","volume":"108","author":"Christoffersen","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.clinbiochem.2015.03.019_bb0240","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.atherosclerosis.2013.04.024","article-title":"Liver involvement in sphingosine 1-phosphate dynamism revealed by adenoviral hepatic overexpression of apolipoprotein M","volume":"229","author":"Kurano","year":"2013","journal-title":"Atherosclerosis"}],"container-title":["Clinical Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009912015001174?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009912015001174?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T15:46:27Z","timestamp":1757864787000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009912015001174"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7]]},"references-count":44,"journal-issue":{"issue":"10-11","published-print":{"date-parts":[[2015,7]]}},"alternative-id":["S0009912015001174"],"URL":"https:\/\/doi.org\/10.1016\/j.clinbiochem.2015.03.019","relation":{},"ISSN":["0009-9120"],"issn-type":[{"type":"print","value":"0009-9120"}],"subject":[],"published":{"date-parts":[[2015,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Possible involvement of sphingomyelin in the regulation of the plasma sphingosine 1-phosphate level in human subjects","name":"articletitle","label":"Article Title"},{"value":"Clinical Biochemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinbiochem.2015.03.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 The Canadian Society of Clinical Chemists. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}